WHO Oropharynx and Nasopharynx

Page 1: Update on WHO Classification of Head and Neck Tumors

The 5th edition of the WHO classification provides a comprehensive overview of lesions, focusing on their clinical, epidemiological, histological, immunohistochemical, molecular, and genetic features.
Significant updates were made regarding oropharyngeal and nasopharyngeal lesions.

WHO Classification: An official reference for diagnosing and classifying tumors.
Oropharyngeal Carcinoma: Cancers located in the oropharynx.
Nasopharyngeal Carcinoma: Cancers occurring in the nasopharynx.
HPV (Human Papillomavirus): A virus identified as a major risk factor for oropharyngeal cancers.
EBV (Epstein-Barr Virus): A virus associated primarily with nasopharyngeal carcinomas.

The new classification incorporates significant changes for oropharyngeal (Chapter 6) and nasopharyngeal (Chapter 4) lesions, particularly highlighting the role of viral infections as risk factors.

The oropharynx extends from the soft palate to the level of the hyoid bone and includes structures such as the base of the tongue and tonsils.
Differences in HPV-related and non-HPV-related carcinomas are emphasized due to their varying histological and clinical manifestations.
Several topics related to salivary glands and neuroendocrine tumors have been relocated to reduce redundancy.
Hamartomatous Polyps: Recognizing these rare, benign lesions is crucial to avoid misdiagnosis. They have varying components, including adipocytes and lymphatic channels.
Complete surgical excision leads to no recurrence.

##Overview of HNSCC

Head and neck SCCs are classified malignant tumors that encompass multiple regions in the head and neck area and account for significant incidence and mortality rates globally.
Risk Factors: Smoking, alcohol consumption, and HPV are critical in the etiology of oropharyngeal cancers (OPSCC).

The incidence of HPV in OPSCC varies significantly by geographic region, being more prevalent in North America and Northern Europe.
Demographics: Typically impacts white males of high socioeconomic status, often linked to sexual practices.
HPV-associated cancers may occur in younger age groups but also in older patients depending on sociocultural contexts.

Distinct histologic features of the tonsillar crypt epithelium compared to surface epithelium are noted, emphasizing challenges in diagnosis due to lymphocyte infiltration.
Most common histologic types in HPV-associated OPSCC include varying subtypes with specific characteristics outlined.

Specific histological features include high nuclear/cytoplasmic ratios without significant keratinization.
Accumulations of evidence suggest that HPV-related tumors present with infiltrative characteristics and tendencies toward metastasis.
Extranodal extension in HPV-associated cancers presents a greater frequency and has implications for prognosis.

HPV High-risk types are directly associated with OPSCC. High-risk types express E6 and E7 oncoproteins that affect tumor suppressor genes.
Immunostaining: P16 protein serves as an indirect marker for HPV infection, critical for diagnosis and treatment stratification.
Recommended testing methods have varying benefits and drawbacks, with p16 immunostaining being favored for practical application in clinical settings.

Comprehensive guidelines recommend testing all OPSCC samples for HPV and assessing mutational profiles for personalized treatment.
Differences found between HPV-associated and independent tumors in terms of genetic mutations influenced outcomes.

HPV-positive OPSCC shows favorable prognosis, with a higher response rate to treatment compared to HPV-negative OPSCC.
Current efforts are being made to refine treatment protocols based on HPV status, emphasizing the significance of understanding the associated biological mechanisms.

HPV-independent OPSCC largely arises from traditional risk factors encompassing alcohol and tobacco.
Histopathological profiles differ, often displaying keratinizing forms of SCC characterized by specific markers.

The nasopharynx chapter in the 5th edition emphasizes the particular tumors common to the region and addresses lymphomas specifically associated with EBV.
Malignant lesions, benign, and borderline cases are outlined.

Examples include hairy polyp and salivary gland anlage tumors, with unique histological characteristics.

NPC is classified based on morphologic features, with clear associations to EBV in endemic regions.
Understanding risk factors and epidemiology plays a crucial role in NPC management and patient education.

NPC exhibits a common histology of non-keratinizing SCC, with specific cytological variations.
Differentiating features include the immunohistochemical profile and the recommendation for EBV testing.

The progression of NPC from dysplastic lesions to malignant tumors follows distinct genetic pathways.
Staging systems need to incorporate both histological and virological datasets to provide accurate prognostic predictions.

The 2022 WHO classification introduces changes aimed at delineating clearer diagnostic guidelines for oropharyngeal and nasopharyngeal tumors.
The integration of genomic and biomarker studies will aid in understanding tumor biology and therapy responses.

The new WHO classification provides refined categories within oropharyngeal and nasopharyngeal lesions, ensuring pathologists can identify and characterize tumors more effectively.
Acknowledges the need for ongoing research to bridge gaps in understanding HPV's role in head and neck malignancies.